期刊文献+

间歇充气压力泵预防慢性阻塞性肺疾病患者下肢深静脉血栓形成的效果 被引量:4

The application of intermittent aeration pressure pump in the prevention of deep venous thrombosis of lower extremity in patients with chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的探讨间歇充气压力泵与低分子肝素联合应用在预防慢性阻塞性肺疾病患者下肢深静脉血栓形成中的效果。方法选取85例慢性阻塞性肺疾病患者,在入院时随机分成两组,对照组予常规护理及使用低分子肝素预防深静脉血栓形成,观察组在对照组的基础上联合应用间歇充气加压泵。结果对照组发生深静脉血栓形成6例(13.9%),观察组发生2例(4.76%),观察组深静脉血栓形成发生率低于对照组,差异有统计学意义(P<0.05)。结论间歇充气加压泵与低分子肝素联合应用可有效预防慢性阻塞性肺疾病下肢深静脉血栓的形成。 Objective To explore the effect of intermittent aeration pressure pump and low molecular heparin in preventing the formation of deep venous thrombosis of lower extremity in patients with chronic obstructive pulmonary disease.Methods 85 cases of patients with chronic obstructive pulmonary disease in the hospital is divided into two groups at random, the control to conventional nursing care and use of low molecular heparin to prevent deep vein thrombosis, On the basis of the control group, the observation group combined with the intermittent pneumatic pressure pump.Results In the control group, there were 6 cases of deep venous thrombosis(13.9%) and 2 cases(4.76%) in the observation group. The incidence of deep venous thrombosis in the observation group was lower than that in the control group, and the difference was statistically significant(P<0.05).Conclusion The combined application of intermittent air pressure pump and low molecular heparin can effectively prevent the formation of deep venous thrombosis of lower extremity of chronic obstructive pulmonary disease.
出处 《当代护士(下旬刊)》 2019年第6期51-53,共3页 Modern Nurse
关键词 充气压力泵 预防 下肢深静脉血栓 Pneumatic pressure pump Prevention Deep vein thrombosis of lower extremity
  • 相关文献

参考文献3

二级参考文献50

  • 1徐建民.抗凝药治疗静脉血栓[J].中国临床医学,2005,12(4):559-561. 被引量:4
  • 2罗辉遇,谢长江,刘卫江,温德良,张振辉,熊旭明,陈晓辉,胡以则.腹部大手术患者凝血功能的变化及临床意义[J].岭南现代临床外科,2006,6(1):21-23. 被引量:4
  • 3Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med, 1989, 82: 203-205.
  • 4Cardiovascular Disease Educational and Research Trust, Cyprus Cardiovascular Disease Educational and Research Trust, European Venous Forum, et al. Prevention and treatment of venous thromboembolism. International Consensus statement (guidelines according to scientific evidence). Int Angiol, 2006, 25 : 101- 161.
  • 5Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med, 1999, 341 : 793-800.
  • 6Leizorovicz A, Mismetti P. Preventing venous thromboembolism in medical patients. Circulation, 2004, 110 Suppl 1: IV13-IV19.
  • 7Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ, 2006, 332: 325-329.
  • 8Fraisse F, Holzapfel L, Couland JM, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med, 2000, 161: 1109-1114.
  • 9Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA, 1995, 274: 335-337.
  • 10Spyropoulos AC. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Chest, 2005, 128 : 958-969.

共引文献95

同被引文献35

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部